Nocturia Industry Research Report 2023
Highlights
The global Nocturia market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
North American market for Nocturia is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
Asia-Pacific market for Nocturia is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
The major global companies of Nocturia include Astellas Pharma, Allergan, Ferring Pharmaceuticals, Eli Lilly, GlaxoSmithKline, Sanofi, Pfizer, Abbott and Teva, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
The global market for Nocturia in Hospital Pharmacies is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Desmopressin, which accounted for % of the global market of Nocturia in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2024 to 2029.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nocturia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nocturia.
The Nocturia market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Nocturia market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nocturia companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by Nocturia type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Nocturia are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Nocturia segment by Type
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Nocturia market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Nocturia market.
Nocturia Segment by Sale Channels
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Nocturia market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nocturia market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Nocturia and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Nocturia industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nocturia.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Nocturia companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
The global Nocturia market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
North American market for Nocturia is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
Asia-Pacific market for Nocturia is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
The major global companies of Nocturia include Astellas Pharma, Allergan, Ferring Pharmaceuticals, Eli Lilly, GlaxoSmithKline, Sanofi, Pfizer, Abbott and Teva, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
The global market for Nocturia in Hospital Pharmacies is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Desmopressin, which accounted for % of the global market of Nocturia in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2024 to 2029.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nocturia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nocturia.
The Nocturia market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Nocturia market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nocturia companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Astellas Pharma
- Allergan
- Ferring Pharmaceuticals
- Eli Lilly
- GlaxoSmithKline
- Sanofi
- Pfizer
- Abbott
- Teva
- Mylan
- Johnson & Johnson
- Hainan Zhonghe Pharmaceutical
Global markets are presented by Nocturia type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Nocturia are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Nocturia segment by Type
- Desmopressin
- Anticholinergic Drugs
- Alpha Blockers
- Diuretics
- Others
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Nocturia market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Nocturia market.
Nocturia Segment by Sale Channels
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Nocturia market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nocturia market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Nocturia and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Nocturia industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nocturia.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Nocturia companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Nocturia by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 Desmopressin
1.2.3 Anticholinergic Drugs
1.2.4 Alpha Blockers
1.2.5 Diuretics
1.2.6 Others
2.3 Nocturia by Sale Channels
2.3.1 Market Value Comparison by Sale Channels (2018 VS 2022 VS 2029)
2.3.2 Hospital Pharmacies
2.3.3 Retail Pharmacies
2.3.4 Online Pharmacies
2.4 Assumptions and Limitations
3 NOCTURIA BREAKDOWN DATA BY TYPE
3.1 Global Nocturia Historic Market Size by Type (2018-2023)
3.2 Global Nocturia Forecasted Market Size by Type (2023-2028)
4 NOCTURIA BREAKDOWN DATA BY SALE CHANNELS
4.1 Global Nocturia Historic Market Size by Sale Channels (2018-2023)
4.2 Global Nocturia Forecasted Market Size by Sale Channels (2018-2023)
5 GLOBAL GROWTH TRENDS
5.1 Global Nocturia Market Perspective (2018-2029)
5.2 Global Nocturia Growth Trends by Region
5.2.1 Global Nocturia Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Nocturia Historic Market Size by Region (2018-2023)
5.2.3 Nocturia Forecasted Market Size by Region (2024-2029)
5.3 Nocturia Market Dynamics
5.3.1 Nocturia Industry Trends
5.3.2 Nocturia Market Drivers
5.3.3 Nocturia Market Challenges
5.3.4 Nocturia Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Nocturia Players by Revenue
6.1.1 Global Top Nocturia Players by Revenue (2018-2023)
6.1.2 Global Nocturia Revenue Market Share by Players (2018-2023)
6.2 Global Nocturia Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Nocturia Head office and Area Served
6.4 Global Nocturia Players, Product Type & Application
6.5 Global Nocturia Players, Date of Enter into This Industry
6.6 Global Nocturia Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Nocturia Market Size (2018-2029)
7.2 North America Nocturia Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Nocturia Market Size by Country (2018-2023)
7.4 North America Nocturia Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Nocturia Market Size (2018-2029)
8.2 Europe Nocturia Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Nocturia Market Size by Country (2018-2023)
8.4 Europe Nocturia Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Nocturia Market Size (2018-2029)
9.2 Asia-Pacific Nocturia Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Nocturia Market Size by Country (2018-2023)
9.4 Asia-Pacific Nocturia Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 LATIN AMERICA
10.1 Latin America Nocturia Market Size (2018-2029)
10.2 Latin America Nocturia Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Nocturia Market Size by Country (2018-2023)
10.4 Latin America Nocturia Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Nocturia Market Size (2018-2029)
11.2 Middle East & Africa Nocturia Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Nocturia Market Size by Country (2018-2023)
11.4 Middle East & Africa Nocturia Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 PLAYERS PROFILED
11.1 Astellas Pharma
11.1.1 Astellas Pharma Company Detail
11.1.2 Astellas Pharma Business Overview
11.1.3 Astellas Pharma Nocturia Introduction
11.1.4 Astellas Pharma Revenue in Nocturia Business (2017-2022)
11.1.5 Astellas Pharma Recent Development
11.2 Allergan
11.2.1 Allergan Company Detail
11.2.2 Allergan Business Overview
11.2.3 Allergan Nocturia Introduction
11.2.4 Allergan Revenue in Nocturia Business (2017-2022)
11.2.5 Allergan Recent Development
11.3 Ferring Pharmaceuticals
11.3.1 Ferring Pharmaceuticals Company Detail
11.3.2 Ferring Pharmaceuticals Business Overview
11.3.3 Ferring Pharmaceuticals Nocturia Introduction
11.3.4 Ferring Pharmaceuticals Revenue in Nocturia Business (2017-2022)
11.3.5 Ferring Pharmaceuticals Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Detail
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Nocturia Introduction
11.4.4 Eli Lilly Revenue in Nocturia Business (2017-2022)
11.4.5 Eli Lilly Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Nocturia Introduction
11.5.4 GlaxoSmithKline Revenue in Nocturia Business (2017-2022)
11.5.5 GlaxoSmithKline Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Detail
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Nocturia Introduction
11.6.4 Sanofi Revenue in Nocturia Business (2017-2022)
11.6.5 Sanofi Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Nocturia Introduction
11.7.4 Pfizer Revenue in Nocturia Business (2017-2022)
11.7.5 Pfizer Recent Development
11.8 Abbott
11.8.1 Abbott Company Detail
11.8.2 Abbott Business Overview
11.8.3 Abbott Nocturia Introduction
11.8.4 Abbott Revenue in Nocturia Business (2017-2022)
11.8.5 Abbott Recent Development
11.9 Teva
11.9.1 Teva Company Detail
11.9.2 Teva Business Overview
11.9.3 Teva Nocturia Introduction
11.9.4 Teva Revenue in Nocturia Business (2017-2022)
11.9.5 Teva Recent Development
11.10 Mylan
11.10.1 Mylan Company Detail
11.10.2 Mylan Business Overview
11.10.3 Mylan Nocturia Introduction
11.10.4 Mylan Revenue in Nocturia Business (2017-2022)
11.10.5 Mylan Recent Development
11.11 Johnson & Johnson
11.11.1 Johnson & Johnson Company Detail
11.11.2 Johnson & Johnson Business Overview
11.11.3 Johnson & Johnson Nocturia Introduction
11.11.4 Johnson & Johnson Revenue in Nocturia Business (2017-2022)
11.11.5 Johnson & Johnson Recent Development
11.12 Hainan Zhonghe Pharmaceutical
11.12.1 Hainan Zhonghe Pharmaceutical Company Detail
11.12.2 Hainan Zhonghe Pharmaceutical Business Overview
11.12.3 Hainan Zhonghe Pharmaceutical Nocturia Introduction
11.12.4 Hainan Zhonghe Pharmaceutical Revenue in Nocturia Business (2017-2022)
11.12.5 Hainan Zhonghe Pharmaceutical Recent Development
13 REPORT CONCLUSION
14 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Nocturia by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 Desmopressin
1.2.3 Anticholinergic Drugs
1.2.4 Alpha Blockers
1.2.5 Diuretics
1.2.6 Others
2.3 Nocturia by Sale Channels
2.3.1 Market Value Comparison by Sale Channels (2018 VS 2022 VS 2029)
2.3.2 Hospital Pharmacies
2.3.3 Retail Pharmacies
2.3.4 Online Pharmacies
2.4 Assumptions and Limitations
3 NOCTURIA BREAKDOWN DATA BY TYPE
3.1 Global Nocturia Historic Market Size by Type (2018-2023)
3.2 Global Nocturia Forecasted Market Size by Type (2023-2028)
4 NOCTURIA BREAKDOWN DATA BY SALE CHANNELS
4.1 Global Nocturia Historic Market Size by Sale Channels (2018-2023)
4.2 Global Nocturia Forecasted Market Size by Sale Channels (2018-2023)
5 GLOBAL GROWTH TRENDS
5.1 Global Nocturia Market Perspective (2018-2029)
5.2 Global Nocturia Growth Trends by Region
5.2.1 Global Nocturia Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Nocturia Historic Market Size by Region (2018-2023)
5.2.3 Nocturia Forecasted Market Size by Region (2024-2029)
5.3 Nocturia Market Dynamics
5.3.1 Nocturia Industry Trends
5.3.2 Nocturia Market Drivers
5.3.3 Nocturia Market Challenges
5.3.4 Nocturia Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Nocturia Players by Revenue
6.1.1 Global Top Nocturia Players by Revenue (2018-2023)
6.1.2 Global Nocturia Revenue Market Share by Players (2018-2023)
6.2 Global Nocturia Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Nocturia Head office and Area Served
6.4 Global Nocturia Players, Product Type & Application
6.5 Global Nocturia Players, Date of Enter into This Industry
6.6 Global Nocturia Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Nocturia Market Size (2018-2029)
7.2 North America Nocturia Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Nocturia Market Size by Country (2018-2023)
7.4 North America Nocturia Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Nocturia Market Size (2018-2029)
8.2 Europe Nocturia Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Nocturia Market Size by Country (2018-2023)
8.4 Europe Nocturia Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Nocturia Market Size (2018-2029)
9.2 Asia-Pacific Nocturia Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Nocturia Market Size by Country (2018-2023)
9.4 Asia-Pacific Nocturia Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 LATIN AMERICA
10.1 Latin America Nocturia Market Size (2018-2029)
10.2 Latin America Nocturia Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Nocturia Market Size by Country (2018-2023)
10.4 Latin America Nocturia Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Nocturia Market Size (2018-2029)
11.2 Middle East & Africa Nocturia Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Nocturia Market Size by Country (2018-2023)
11.4 Middle East & Africa Nocturia Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 PLAYERS PROFILED
11.1 Astellas Pharma
11.1.1 Astellas Pharma Company Detail
11.1.2 Astellas Pharma Business Overview
11.1.3 Astellas Pharma Nocturia Introduction
11.1.4 Astellas Pharma Revenue in Nocturia Business (2017-2022)
11.1.5 Astellas Pharma Recent Development
11.2 Allergan
11.2.1 Allergan Company Detail
11.2.2 Allergan Business Overview
11.2.3 Allergan Nocturia Introduction
11.2.4 Allergan Revenue in Nocturia Business (2017-2022)
11.2.5 Allergan Recent Development
11.3 Ferring Pharmaceuticals
11.3.1 Ferring Pharmaceuticals Company Detail
11.3.2 Ferring Pharmaceuticals Business Overview
11.3.3 Ferring Pharmaceuticals Nocturia Introduction
11.3.4 Ferring Pharmaceuticals Revenue in Nocturia Business (2017-2022)
11.3.5 Ferring Pharmaceuticals Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Detail
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Nocturia Introduction
11.4.4 Eli Lilly Revenue in Nocturia Business (2017-2022)
11.4.5 Eli Lilly Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Nocturia Introduction
11.5.4 GlaxoSmithKline Revenue in Nocturia Business (2017-2022)
11.5.5 GlaxoSmithKline Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Detail
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Nocturia Introduction
11.6.4 Sanofi Revenue in Nocturia Business (2017-2022)
11.6.5 Sanofi Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Nocturia Introduction
11.7.4 Pfizer Revenue in Nocturia Business (2017-2022)
11.7.5 Pfizer Recent Development
11.8 Abbott
11.8.1 Abbott Company Detail
11.8.2 Abbott Business Overview
11.8.3 Abbott Nocturia Introduction
11.8.4 Abbott Revenue in Nocturia Business (2017-2022)
11.8.5 Abbott Recent Development
11.9 Teva
11.9.1 Teva Company Detail
11.9.2 Teva Business Overview
11.9.3 Teva Nocturia Introduction
11.9.4 Teva Revenue in Nocturia Business (2017-2022)
11.9.5 Teva Recent Development
11.10 Mylan
11.10.1 Mylan Company Detail
11.10.2 Mylan Business Overview
11.10.3 Mylan Nocturia Introduction
11.10.4 Mylan Revenue in Nocturia Business (2017-2022)
11.10.5 Mylan Recent Development
11.11 Johnson & Johnson
11.11.1 Johnson & Johnson Company Detail
11.11.2 Johnson & Johnson Business Overview
11.11.3 Johnson & Johnson Nocturia Introduction
11.11.4 Johnson & Johnson Revenue in Nocturia Business (2017-2022)
11.11.5 Johnson & Johnson Recent Development
11.12 Hainan Zhonghe Pharmaceutical
11.12.1 Hainan Zhonghe Pharmaceutical Company Detail
11.12.2 Hainan Zhonghe Pharmaceutical Business Overview
11.12.3 Hainan Zhonghe Pharmaceutical Nocturia Introduction
11.12.4 Hainan Zhonghe Pharmaceutical Revenue in Nocturia Business (2017-2022)
11.12.5 Hainan Zhonghe Pharmaceutical Recent Development
13 REPORT CONCLUSION
14 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Sale Channels (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Nocturia Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Nocturia Revenue Market Share by Type (2018-2023)
Table 7. Global Nocturia Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Nocturia Revenue Market Share by Type (2024-2029)
Table 9. Global Nocturia Market Size by Sale Channels (2018-2023) & (US$ Million)
Table 10. Global Nocturia Revenue Market Share by Sale Channels (2018-2023)
Table 11. Global Nocturia Forecasted Market Size by Sale Channels (2024-2029) & (US$ Million)
Table 12. Global Nocturia Revenue Market Share by Sale Channels (2024-2029)
Table 13. Global Nocturia Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Nocturia Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Nocturia Market Share by Region (2018-2023)
Table 16. Global Nocturia Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Nocturia Market Share by Region (2024-2029)
Table 18. Nocturia Market Trends
Table 19. Nocturia Market Drivers
Table 20. Nocturia Market Challenges
Table 21. Nocturia Market Restraints
Table 22. Global Top Nocturia Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Nocturia Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Nocturia Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Nocturia, Headquarters and Area Served
Table 26. Global Nocturia Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Nocturia by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Nocturia Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Nocturia Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Nocturia Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Nocturia Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Nocturia Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Nocturia Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Nocturia Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Nocturia Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Nocturia Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Nocturia Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Nocturia Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Nocturia Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Nocturia Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Nocturia Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Nocturia Market Size by Country (2024-2029) & (US$ Million)
Table 45. Astellas Pharma Company Detail
Table 46. Astellas Pharma Business Overview
Table 47. Astellas Pharma Nocturia Product
Table 48. Astellas Pharma Revenue in Nocturia Business (2017-2022) & (US$ Million)
Table 49. Astellas Pharma Recent Development
Table 50. Allergan Company Detail
Table 51. Allergan Business Overview
Table 52. Allergan Nocturia Product
Table 53. Allergan Revenue in Nocturia Business (2017-2022) & (US$ Million)
Table 54. Allergan Recent Development
Table 55. Ferring Pharmaceuticals Company Detail
Table 56. Ferring Pharmaceuticals Business Overview
Table 57. Ferring Pharmaceuticals Nocturia Product
Table 58. Ferring Pharmaceuticals Revenue in Nocturia Business (2017-2022) & (US$ Million)
Table 59. Ferring Pharmaceuticals Recent Development
Table 60. Eli Lilly Company Detail
Table 61. Eli Lilly Business Overview
Table 62. Eli Lilly Nocturia Product
Table 63. Eli Lilly Revenue in Nocturia Business (2017-2022) & (US$ Million)
Table 64. Eli Lilly Recent Development
Table 65. GlaxoSmithKline Company Detail
Table 66. GlaxoSmithKline Business Overview
Table 67. GlaxoSmithKline Nocturia Product
Table 68. GlaxoSmithKline Revenue in Nocturia Business (2017-2022) & (US$ Million)
Table 69. GlaxoSmithKline Recent Development
Table 70. Sanofi Company Detail
Table 71. Sanofi Business Overview
Table 72. Sanofi Nocturia Product
Table 73. Sanofi Revenue in Nocturia Business (2017-2022) & (US$ Million)
Table 74. Sanofi Recent Development
Table 75. Pfizer Company Detail
Table 76. Pfizer Business Overview
Table 77. Pfizer Nocturia Product
Table 78. Pfizer Revenue in Nocturia Business (2017-2022) & (US$ Million)
Table 79. Pfizer Recent Development
Table 80. Abbott Company Detail
Table 81. Abbott Business Overview
Table 82. Abbott Nocturia Product
Table 83. Abbott Revenue in Nocturia Business (2017-2022) & (US$ Million)
Table 84. Abbott Recent Development
Table 85. Teva Company Detail
Table 86. Teva Business Overview
Table 87. Teva Nocturia Product
Table 88. Teva Revenue in Nocturia Business (2017-2022) & (US$ Million)
Table 89. Teva Recent Development
Table 90. Mylan Company Detail
Table 91. Mylan Business Overview
Table 92. Mylan Nocturia Product
Table 93. Mylan Revenue in Nocturia Business (2017-2022) & (US$ Million)
Table 94. Mylan Recent Development
Table 95. Johnson & Johnson Company Detail
Table 96. Johnson & Johnson Business Overview
Table 97. Johnson & Johnson NocturiaProduct
Table 98. Johnson & Johnson Revenue in Nocturia Business (2017-2022) & (US$ Million)
Table 99. Johnson & Johnson Recent Development
Table 100. Hainan Zhonghe Pharmaceutical Company Detail
Table 101. Hainan Zhonghe Pharmaceutical Business Overview
Table 102. Hainan Zhonghe Pharmaceutical NocturiaProduct
Table 103. Hainan Zhonghe Pharmaceutical Revenue in Nocturia Business (2017-2022) & (US$ Million)
Table 104. Hainan Zhonghe Pharmaceutical Recent Development
Table 105. Astellas Pharma Company Information
Table 106. Astellas Pharma Business Overview
Table 107. Astellas Pharma Nocturia Revenue in Nocturia Business (2018-2023) & (US$ Million)
Table 108. Astellas Pharma Revenue in Nocturia Business (2018-2023) & (US$ Million) Portfolio
Table 109. Astellas Pharma Recent Development
Table 110. Allergan Company Information
Table 111. Allergan Business Overview
Table 112. Allergan Nocturia Revenue in Nocturia Business (2018-2023) & (US$ Million)
Table 113. Allergan Revenue in Nocturia Business (2018-2023) & (US$ Million) Portfolio
Table 114. Allergan Recent Development
Table 115. Ferring Pharmaceuticals Company Information
Table 116. Ferring Pharmaceuticals Business Overview
Table 117. Ferring Pharmaceuticals Nocturia Revenue in Nocturia Business (2018-2023) & (US$ Million)
Table 118. Ferring Pharmaceuticals Revenue in Nocturia Business (2018-2023) & (US$ Million) Portfolio
Table 119. Ferring Pharmaceuticals Recent Development
Table 120. Eli Lilly Company Information
Table 121. Eli Lilly Business Overview
Table 122. Eli Lilly Nocturia Revenue in Nocturia Business (2018-2023) & (US$ Million)
Table 123. Eli Lilly Revenue in Nocturia Business (2018-2023) & (US$ Million) Portfolio
Table 124. Eli Lilly Recent Development
Table 125. GlaxoSmithKline Company Information
Table 126. GlaxoSmithKline Business Overview
Table 127. GlaxoSmithKline Nocturia Revenue in Nocturia Business (2018-2023) & (US$ Million)
Table 128. GlaxoSmithKline Revenue in Nocturia Business (2018-2023) & (US$ Million) Portfolio
Table 129. GlaxoSmithKline Recent Development
Table 130. Sanofi Company Information
Table 131. Sanofi Business Overview
Table 132. Sanofi Nocturia Revenue in Nocturia Business (2018-2023) & (US$ Million)
Table 133. Sanofi Revenue in Nocturia Business (2018-2023) & (US$ Million) Portfolio
Table 134. Sanofi Recent Development
Table 135. Pfizer Company Information
Table 136. Pfizer Business Overview
Table 137. Pfizer Nocturia Revenue in Nocturia Business (2018-2023) & (US$ Million)
Table 138. Pfizer Revenue in Nocturia Business (2018-2023) & (US$ Million) Portfolio
Table 139. Pfizer Recent Development
Table 140. Abbott Company Information
Table 141. Abbott Business Overview
Table 142. Abbott Nocturia Revenue in Nocturia Business (2018-2023) & (US$ Million)
Table 143. Abbott Revenue in Nocturia Business (2018-2023) & (US$ Million) Portfolio
Table 144. Abbott Recent Development
Table 145. Teva Company Information
Table 146. Teva Business Overview
Table 147. Teva Nocturia Revenue in Nocturia Business (2018-2023) & (US$ Million)
Table 148. Teva Revenue in Nocturia Business (2018-2023) & (US$ Million) Portfolio
Table 149. Teva Recent Development
Table 150. Mylan Company Information
Table 151. Mylan Business Overview
Table 152. Mylan Nocturia Revenue in Nocturia Business (2018-2023) & (US$ Million)
Table 153. Mylan Revenue in Nocturia Business (2018-2023) & (US$ Million) Portfolio
Table 154. Mylan Recent Development
Table 155. Johnson & Johnson Company Information
Table 156. Johnson & Johnson Business Overview
Table 157. Johnson & Johnson NocturiaRevenue in Nocturia Business (2018-2023) & (US$ Million)
Table 158. Johnson & Johnson Revenue in Nocturia Business (2018-2023) & (US$ Million) Portfolio
Table 159. Johnson & Johnson Recent Development
Table 160. Hainan Zhonghe Pharmaceutical Company Information
Table 161. Hainan Zhonghe Pharmaceutical Business Overview
Table 162. Hainan Zhonghe Pharmaceutical NocturiaRevenue in Nocturia Business (2018-2023) & (US$ Million)
Table 163. Hainan Zhonghe Pharmaceutical Revenue in Nocturia Business (2018-2023) & (US$ Million) Portfolio
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Sale Channels (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Nocturia Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Nocturia Revenue Market Share by Type (2018-2023)
Table 7. Global Nocturia Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Nocturia Revenue Market Share by Type (2024-2029)
Table 9. Global Nocturia Market Size by Sale Channels (2018-2023) & (US$ Million)
Table 10. Global Nocturia Revenue Market Share by Sale Channels (2018-2023)
Table 11. Global Nocturia Forecasted Market Size by Sale Channels (2024-2029) & (US$ Million)
Table 12. Global Nocturia Revenue Market Share by Sale Channels (2024-2029)
Table 13. Global Nocturia Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Nocturia Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Nocturia Market Share by Region (2018-2023)
Table 16. Global Nocturia Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Nocturia Market Share by Region (2024-2029)
Table 18. Nocturia Market Trends
Table 19. Nocturia Market Drivers
Table 20. Nocturia Market Challenges
Table 21. Nocturia Market Restraints
Table 22. Global Top Nocturia Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Nocturia Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Nocturia Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Nocturia, Headquarters and Area Served
Table 26. Global Nocturia Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Nocturia by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Nocturia Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Nocturia Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Nocturia Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Nocturia Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Nocturia Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Nocturia Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Nocturia Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Nocturia Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Nocturia Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Nocturia Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Nocturia Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Nocturia Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Nocturia Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Nocturia Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Nocturia Market Size by Country (2024-2029) & (US$ Million)
Table 45. Astellas Pharma Company Detail
Table 46. Astellas Pharma Business Overview
Table 47. Astellas Pharma Nocturia Product
Table 48. Astellas Pharma Revenue in Nocturia Business (2017-2022) & (US$ Million)
Table 49. Astellas Pharma Recent Development
Table 50. Allergan Company Detail
Table 51. Allergan Business Overview
Table 52. Allergan Nocturia Product
Table 53. Allergan Revenue in Nocturia Business (2017-2022) & (US$ Million)
Table 54. Allergan Recent Development
Table 55. Ferring Pharmaceuticals Company Detail
Table 56. Ferring Pharmaceuticals Business Overview
Table 57. Ferring Pharmaceuticals Nocturia Product
Table 58. Ferring Pharmaceuticals Revenue in Nocturia Business (2017-2022) & (US$ Million)
Table 59. Ferring Pharmaceuticals Recent Development
Table 60. Eli Lilly Company Detail
Table 61. Eli Lilly Business Overview
Table 62. Eli Lilly Nocturia Product
Table 63. Eli Lilly Revenue in Nocturia Business (2017-2022) & (US$ Million)
Table 64. Eli Lilly Recent Development
Table 65. GlaxoSmithKline Company Detail
Table 66. GlaxoSmithKline Business Overview
Table 67. GlaxoSmithKline Nocturia Product
Table 68. GlaxoSmithKline Revenue in Nocturia Business (2017-2022) & (US$ Million)
Table 69. GlaxoSmithKline Recent Development
Table 70. Sanofi Company Detail
Table 71. Sanofi Business Overview
Table 72. Sanofi Nocturia Product
Table 73. Sanofi Revenue in Nocturia Business (2017-2022) & (US$ Million)
Table 74. Sanofi Recent Development
Table 75. Pfizer Company Detail
Table 76. Pfizer Business Overview
Table 77. Pfizer Nocturia Product
Table 78. Pfizer Revenue in Nocturia Business (2017-2022) & (US$ Million)
Table 79. Pfizer Recent Development
Table 80. Abbott Company Detail
Table 81. Abbott Business Overview
Table 82. Abbott Nocturia Product
Table 83. Abbott Revenue in Nocturia Business (2017-2022) & (US$ Million)
Table 84. Abbott Recent Development
Table 85. Teva Company Detail
Table 86. Teva Business Overview
Table 87. Teva Nocturia Product
Table 88. Teva Revenue in Nocturia Business (2017-2022) & (US$ Million)
Table 89. Teva Recent Development
Table 90. Mylan Company Detail
Table 91. Mylan Business Overview
Table 92. Mylan Nocturia Product
Table 93. Mylan Revenue in Nocturia Business (2017-2022) & (US$ Million)
Table 94. Mylan Recent Development
Table 95. Johnson & Johnson Company Detail
Table 96. Johnson & Johnson Business Overview
Table 97. Johnson & Johnson NocturiaProduct
Table 98. Johnson & Johnson Revenue in Nocturia Business (2017-2022) & (US$ Million)
Table 99. Johnson & Johnson Recent Development
Table 100. Hainan Zhonghe Pharmaceutical Company Detail
Table 101. Hainan Zhonghe Pharmaceutical Business Overview
Table 102. Hainan Zhonghe Pharmaceutical NocturiaProduct
Table 103. Hainan Zhonghe Pharmaceutical Revenue in Nocturia Business (2017-2022) & (US$ Million)
Table 104. Hainan Zhonghe Pharmaceutical Recent Development
Table 105. Astellas Pharma Company Information
Table 106. Astellas Pharma Business Overview
Table 107. Astellas Pharma Nocturia Revenue in Nocturia Business (2018-2023) & (US$ Million)
Table 108. Astellas Pharma Revenue in Nocturia Business (2018-2023) & (US$ Million) Portfolio
Table 109. Astellas Pharma Recent Development
Table 110. Allergan Company Information
Table 111. Allergan Business Overview
Table 112. Allergan Nocturia Revenue in Nocturia Business (2018-2023) & (US$ Million)
Table 113. Allergan Revenue in Nocturia Business (2018-2023) & (US$ Million) Portfolio
Table 114. Allergan Recent Development
Table 115. Ferring Pharmaceuticals Company Information
Table 116. Ferring Pharmaceuticals Business Overview
Table 117. Ferring Pharmaceuticals Nocturia Revenue in Nocturia Business (2018-2023) & (US$ Million)
Table 118. Ferring Pharmaceuticals Revenue in Nocturia Business (2018-2023) & (US$ Million) Portfolio
Table 119. Ferring Pharmaceuticals Recent Development
Table 120. Eli Lilly Company Information
Table 121. Eli Lilly Business Overview
Table 122. Eli Lilly Nocturia Revenue in Nocturia Business (2018-2023) & (US$ Million)
Table 123. Eli Lilly Revenue in Nocturia Business (2018-2023) & (US$ Million) Portfolio
Table 124. Eli Lilly Recent Development
Table 125. GlaxoSmithKline Company Information
Table 126. GlaxoSmithKline Business Overview
Table 127. GlaxoSmithKline Nocturia Revenue in Nocturia Business (2018-2023) & (US$ Million)
Table 128. GlaxoSmithKline Revenue in Nocturia Business (2018-2023) & (US$ Million) Portfolio
Table 129. GlaxoSmithKline Recent Development
Table 130. Sanofi Company Information
Table 131. Sanofi Business Overview
Table 132. Sanofi Nocturia Revenue in Nocturia Business (2018-2023) & (US$ Million)
Table 133. Sanofi Revenue in Nocturia Business (2018-2023) & (US$ Million) Portfolio
Table 134. Sanofi Recent Development
Table 135. Pfizer Company Information
Table 136. Pfizer Business Overview
Table 137. Pfizer Nocturia Revenue in Nocturia Business (2018-2023) & (US$ Million)
Table 138. Pfizer Revenue in Nocturia Business (2018-2023) & (US$ Million) Portfolio
Table 139. Pfizer Recent Development
Table 140. Abbott Company Information
Table 141. Abbott Business Overview
Table 142. Abbott Nocturia Revenue in Nocturia Business (2018-2023) & (US$ Million)
Table 143. Abbott Revenue in Nocturia Business (2018-2023) & (US$ Million) Portfolio
Table 144. Abbott Recent Development
Table 145. Teva Company Information
Table 146. Teva Business Overview
Table 147. Teva Nocturia Revenue in Nocturia Business (2018-2023) & (US$ Million)
Table 148. Teva Revenue in Nocturia Business (2018-2023) & (US$ Million) Portfolio
Table 149. Teva Recent Development
Table 150. Mylan Company Information
Table 151. Mylan Business Overview
Table 152. Mylan Nocturia Revenue in Nocturia Business (2018-2023) & (US$ Million)
Table 153. Mylan Revenue in Nocturia Business (2018-2023) & (US$ Million) Portfolio
Table 154. Mylan Recent Development
Table 155. Johnson & Johnson Company Information
Table 156. Johnson & Johnson Business Overview
Table 157. Johnson & Johnson NocturiaRevenue in Nocturia Business (2018-2023) & (US$ Million)
Table 158. Johnson & Johnson Revenue in Nocturia Business (2018-2023) & (US$ Million) Portfolio
Table 159. Johnson & Johnson Recent Development
Table 160. Hainan Zhonghe Pharmaceutical Company Information
Table 161. Hainan Zhonghe Pharmaceutical Business Overview
Table 162. Hainan Zhonghe Pharmaceutical NocturiaRevenue in Nocturia Business (2018-2023) & (US$ Million)
Table 163. Hainan Zhonghe Pharmaceutical Revenue in Nocturia Business (2018-2023) & (US$ Million) Portfolio
